{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:50:52Z","timestamp":1793224252980,"version":"4.5.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"COcoa Supplement and Multivitamin Outcomes Study","award":["HL157665"],"award-info":[{"award-number":["HL157665"]}]},{"name":"COcoa Supplement and Multivitamin Outcomes Study","award":["EY025623"],"award-info":[{"award-number":["EY025623"]}]},{"name":"COcoa Supplement and Multivitamin Outcomes Study","award":["AG071611"],"award-info":[{"award-number":["AG071611"]}]},{"name":"COcoa Supplement and Multivitamin Outcomes Study","award":["AG050657"],"award-info":[{"award-number":["AG050657"]}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1UL1TR002541-01"],"award-info":[{"award-number":["1UL1TR002541-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1UL1TR001102"],"award-info":[{"award-number":["1UL1TR001102"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"COSMOS: Effects on Falls and Physical Performance","award":["R01AG071611"],"award-info":[{"award-number":["R01AG071611"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Osteoporosis is a major public health problem among older adults. Forty percent of older US adults take multivitamin\/multimineral (MVM) supplementation. The effects of MVM supplementation on fractures are unclear. Preclinical and observational studies suggest that MVM and flavanols may have beneficial effects on bone. We conducted an ancillary study to Cocoa Supplement and Multivitamin Outcomes Study (COSMOS; NCT05232669) designed to investigate incident fracture and injurious falls in 21\u2009442 COSMOS participants (12\u2009666 females aged \u226565\u00a0yr and 8776 males aged \u226560\u00a0yr) randomized in a 2\u2009\u00d7\u20092 factorial design to 1 of 4 intervention groups: cocoa extract\u2009+\u2009MVM, cocoa extract\u2009+\u2009MVM placebo, cocoa extract placebo\u2009+\u2009MVM, or double placebo. The daily cocoa extract supplement contained 500\u00a0mg\/d flavanols and 80\u00a0mg\/d (\u2013)-epicatechin (Mars Edge); the daily MVM supplement was Centrum Silver (Haleon). The median (interquartile range) duration of the intervention was 3.6 (3.2-4.2) yr. Annually, participants self-reported incident fractures. In intention-to-treat analyses, we examined the effects of cocoa extract and MVM on the primary outcomes of total clinical fracture (hip, upper leg, forearm\/wrist, pelvis, upper arm\/shoulder, spine, knee, or other), hip fracture, and nonvertebral fracture, and secondary outcomes of clinical spine, forearm\/wrist, major osteoporotic, and pelvic fracture using Cox proportional hazards models. During the intervention period, 2083 incident clinical fractures occurred. Compared with placebo, cocoa extract was not significantly associated with lower risk of incident clinical fracture (adjusted hazard ratio [aHR] 1.03, 95% CI 0.95-1.12) or nonvertebral fracture (aHR 1.05, 95% CI 0.96-1.14). MVM supplementation was not associated with lower risk of total clinical fracture (aHR 1.09, 95% CI 1.00-1.19), hip fracture (aHR 1.06, 95% CI 0.80-1.42), or nonvertebral fracture (aHR 1.10, 95% CI 1.00-1.20). These findings do not support the use of cocoa extract or MVM to decrease fracture risk in older individuals not selected for pre-existing osteoporosis.<\/jats:p>","DOI":"10.1093\/jbmr\/zjaf030","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:07:58Z","timestamp":1739894878000},"page":"591-602","source":"Crossref","is-referenced-by-count":4,"title":["Effects of cocoa extract supplementation and multivitamin\/multimineral supplements on self-reported fractures in the Cocoa Supplement and Multivitamins Outcomes Study randomized clinical trial"],"prefix":"10.1093","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9441-0198","authenticated-orcid":false,"given":"Carolyn J","family":"Crandall","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine and Health Services Research, Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles , Los Angeles, CA 90024 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Chou","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Hypertension, Brigham and Women\u2019s Hospital , Boston, MA 02115 ,","place":["United States"]},{"name":"Harvard Medical School , Boston, MA 02115 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjung","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Preventive Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, MA 02115 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Ratnarajah","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Hypertension, Brigham and Women\u2019s Hospital , Boston, MA 02115 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy R","family":"Cook","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, MA 02115 ,","place":["United States"]},{"name":"Division of Preventive Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, MA 02115 ,","place":["United States"]},{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health , Boston, MA 02115 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Clar","sequence":"additional","affiliation":[{"name":"Division of Preventive Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, MA 02115 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard D","family":"Sesso","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, MA 02115 ,","place":["United States"]},{"name":"Division of Preventive Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, MA 02115 ,","place":["United States"]},{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health , Boston, MA 02115 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn E","family":"Manson","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, MA 02115 ,","place":["United States"]},{"name":"Division of Preventive Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, MA 02115 ,","place":["United States"]},{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health , Boston, MA 02115 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryl S","family":"LeBoff","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Hypertension, Brigham and Women\u2019s Hospital , Boston, MA 02115 ,","place":["United States"]},{"name":"Harvard Medical School , Boston, MA 02115 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"2025052505463247400_ref1","volume-title":"Bone Health and Osteoporosis: A Report of the Surgeon General. Reports of the Surgeon General","year":"2004"},{"issue":"11","key":"2025052505463247400_ref2","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1002\/jbmr.2269","article-title":"The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine","volume":"29","author":"Wright","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2025052505463247400_ref3","doi-asserted-by":"publisher","first-page":"132531","DOI":"10.1016\/j.foodchem.2022.132531","article-title":"Plant flavonoids: classification, distribution, biosynthesis, and antioxidant activity","volume":"383","author":"Shen","year":"2022","journal-title":"Food Chem"},{"issue":"13","key":"2025052505463247400_ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133119","article-title":"Isolated compounds from Turpinia formosana Nakai Induce Ossification","volume":"20","author":"Imtiyaz","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025052505463247400_ref5","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.2147\/DDDT.S192683","article-title":"Epigallocatechin-3-gallate enhances the osteoblastogenic differentiation of human adipose-derived stem cells","volume":"13","author":"Zhang","year":"2019","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"2025052505463247400_ref6","doi-asserted-by":"publisher","first-page":"6376","DOI":"10.3892\/mmr.2017.7354","article-title":"Amplification by (\u2212)-epigallocatechin gallate of prostaglandin F2alpha-stimulated synthesis of osteoprotegerin in osteoblasts","volume":"16","author":"Sakai","year":"2017","journal-title":"Mol Med Rep"},{"issue":"3","key":"2025052505463247400_ref7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11033-015-3936-0","article-title":"EGCG ameliorates the hypoxia-induced apoptosis and osteogenic differentiation reduction of mesenchymal stem cells via upregulating miR-210","volume":"43","author":"Qiu","year":"2016","journal-title":"Mol Biol Rep"},{"issue":"6","key":"2025052505463247400_ref8","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/1535370215624020","article-title":"Epigallocatechin-3-gallate protects against tumor necrosis factor alpha induced inhibition of osteogenesis of mesenchymal stem cells","volume":"241","author":"Liu","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"issue":"14","key":"2025052505463247400_ref9","doi-asserted-by":"publisher","first-page":"9926","DOI":"10.1074\/jbc.M113.522870","article-title":"(\u2212)-Epicatechin gallate (ECG) stimulates osteoblast differentiation via runt-related transcription factor 2 (RUNX2) and transcriptional coactivator with PDZ-binding motif (TAZ)-mediated transcriptional activation","volume":"289","author":"Byun","year":"2014","journal-title":"J Biol Chem"},{"issue":"3","key":"2025052505463247400_ref10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.phymed.2013.08.026","article-title":"Promoting osteoblast differentiation by the flavanes from Huangshan Maofeng tea is linked to a reduction of oxidative stress","volume":"21","author":"Zeng","year":"2014","journal-title":"Phytomedicine"},{"key":"2025052505463247400_ref11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.prostaglandins.2017.02.001","article-title":"(\u2212)-Epigallocatechin gallate synergistically potentiates prostaglandin E(2)-stimulated osteoprotegerin synthesis in osteoblasts","volume":"128-129","author":"Kuroyanagi","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"16","key":"2025052505463247400_ref12","doi-asserted-by":"publisher","first-page":"7293","DOI":"10.1021\/jf901545u","article-title":"Effects of tea catechins, epigallocatechin, gallocatechin, and gallocatechin gallate, on bone metabolism","volume":"57","author":"Ko","year":"2009","journal-title":"J Agric Food Chem"},{"issue":"4","key":"2025052505463247400_ref13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1248\/bpb.26.523","article-title":"Effects of (+)-catechin on the function of osteoblastic cells","volume":"26","author":"Choi","year":"2003","journal-title":"Biol Pharm Bull"},{"issue":"6","key":"2025052505463247400_ref14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2220\/biomedres.41.269","article-title":"(\u2212)-Epigallocatechin-3-gallate inhibits RANKL-induced osteoclastogenesis via downregulation of NFATc1 and suppression of HO-1-HMGB1-RAGE pathway","volume":"41","author":"Nishioku","year":"2020","journal-title":"Biomed Res"},{"issue":"1","key":"2025052505463247400_ref15","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24010156","article-title":"(\u2212)-Epigallocatechin-3-gallate decreases osteoclastogenesis via modulation of RANKL and osteoprotegrin","volume":"24","author":"Chen","year":"2019","journal-title":"Molecules"},{"issue":"10","key":"2025052505463247400_ref16","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/j.biochi.2013.07.001","article-title":"(\u2212)-Epigallocatechin gallate amplifies interleukin-1-stimulated interleukin-6 synthesis in osteoblast-like MC3T3-E1 cells","volume":"95","author":"Kuroyanagi","year":"2013","journal-title":"Biochimie"},{"issue":"2","key":"2025052505463247400_ref17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.5009\/gnl.2012.6.2.188","article-title":"Epigallocatechin-3-gallate inhibits LPS-induced NF-kappaB and MAPK signaling pathways in bone marrow-derived macrophages","volume":"6","author":"Joo","year":"2012","journal-title":"Gut Liver"},{"issue":"1","key":"2025052505463247400_ref18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1254\/jphs.11082FP","article-title":"Tea polyphenols inhibit rat osteoclast formation and differentiation","volume":"118","author":"Oka","year":"2012","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"2025052505463247400_ref19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1124\/mol.109.057877","article-title":"Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal","volume":"77","author":"Lee","year":"2010","journal-title":"Mol Pharmacol"},{"issue":"1","key":"2025052505463247400_ref20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1042\/CBI20090011","article-title":"Green tea polyphenol (\u2212)-epigallocatechin gallate suppressed the differentiation of murine osteoblastic MC3T3-E1 cells","volume":"34","author":"Kamon","year":"2009","journal-title":"Cell Biol Int"},{"issue":"4","key":"2025052505463247400_ref21","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.bbrc.2009.01.007","article-title":"(\u2212)-Epigallocatechin gallate inhibition of osteoclastic differentiation via NF-kappaB","volume":"379","author":"Lin","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"2025052505463247400_ref22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1055\/s-2008-1073164","article-title":"(\u2212)-Epigallocatechin gallate inhibits basic fibroblast growth factor-stimulated Interleukin-6 synthesis in osteoblasts","volume":"40","author":"Tokuda","year":"2008","journal-title":"Hormone Metabol Res"},{"issue":"1","key":"2025052505463247400_ref23","doi-asserted-by":"publisher","first-page":"291808","DOI":"10.1155\/2008\/291808","article-title":"(\u2212)-Epigallocatechin gallate reduces platelet-derived growth factor-BB-stimulated interleukin-6 synthesis in osteoblasts: suppression of SAPK\/JNK","volume":"2008","author":"Takai","year":"2008","journal-title":"Mediat Inflamm"},{"issue":"3","key":"2025052505463247400_ref24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1600-0765.2006.00935.x","article-title":"(\u2212)-Epigallocatechin gallate induces apoptosis, via caspase activation, in osteoclasts differentiated from RAW 264.7 cells","volume":"42","author":"Yun","year":"2007","journal-title":"J Periodontal Res"},{"issue":"5","key":"2025052505463247400_ref25","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.3892\/mmr.2018.9437","article-title":"Epigallocatechin-3-gallate protects against secondary osteoporosis in a mouse model via the Wnt\/beta-catenin signaling pathway","volume":"18","author":"Xi","year":"2018","journal-title":"Mol Med Rep"},{"issue":"6","key":"2025052505463247400_ref26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/GME.0b013e31828244f0","article-title":"(\u2212)-Epigallocatechin-3-gallate improves bone microarchitecture in ovariectomized rats","volume":"20","author":"Chen","year":"2013","journal-title":"Menopause"},{"issue":"5","key":"2025052505463247400_ref27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s00223-012-9584-7","article-title":"(\u2212)-Epigallocathechin-3-gallate, an AMPK activator, decreases ovariectomy-induced bone loss by suppression of bone resorption","volume":"90","author":"Lee","year":"2012","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"2025052505463247400_ref28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/RCT.0000000000000517","article-title":"Proton magnetic resonance spectroscopy-detected changes of marrow fat content in a rabbit model of osteoporosis treated with epigallocatechin-3-gallate","volume":"41","author":"Liu","year":"2017","journal-title":"J Comput Assist Tomogr"},{"issue":"23","key":"2025052505463247400_ref29","doi-asserted-by":"publisher","first-page":"10564","DOI":"10.1039\/D3FO03233G","article-title":"Epigallocatechin gallate alleviates osteoporosis by regulating the gut microbiota and serum metabolites in rats","volume":"14","author":"Han","year":"2023","journal-title":"Food Funct"},{"issue":"5","key":"2025052505463247400_ref30","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/jbmr.285","article-title":"Associations between dietary flavonoid intakes and bone health in a Scottish population","volume":"26","author":"Hardcastle","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2025052505463247400_ref31","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s00198-014-2763-9","article-title":"Association between dietary intake of flavonoid and bone mineral density in middle aged and elderly Chinese women and men","volume":"25","author":"Zhang","year":"2014","journal-title":"Osteoporos Int"},{"issue":"6","key":"2025052505463247400_ref32","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1093\/ajcn\/nqac055","article-title":"Effect of cocoa flavanol supplementation for prevention of cardiovascular disease events: the COSMOS randomized clinical trial","volume":"115","author":"Sesso","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"2025052505463247400_ref33","doi-asserted-by":"publisher","first-page":"106728","DOI":"10.1016\/j.cct.2022.106728","article-title":"Design and baseline characteristics of participants in the COcoa Supplement and Multivitamin Outcomes Study (COSMOS)","volume":"116","author":"Rist","year":"2022","journal-title":"Contemp Clin Trials"},{"issue":"2","key":"2025052505463247400_ref34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3945\/jn.110.133025","article-title":"Dietary supplement use in the United States, 2003-2006","volume":"141","author":"Bailey","year":"2011","journal-title":"J Nutr"},{"issue":"14","key":"2025052505463247400_ref35","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1001\/jama.2016.14403","article-title":"Trends in dietary supplement use among US adults from 1999-2012","volume":"316","author":"Kantor","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"2025052505463247400_ref36","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.3945\/jn.117.255984","article-title":"Dietary supplement use was very high among older adults in the United States in 2011-2014","volume":"147","author":"Gahche","year":"2017","journal-title":"J Nutr"},{"key":"2025052505463247400_ref37","first-page":"1","article-title":"Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994)","volume":"61","author":"Gahche","year":"2011","journal-title":"NCHS Data Brief"},{"key":"2025052505463247400_ref38","volume-title":"Dietary Reference Intakes for Calcium and Vitamin D","author":"Ross","year":"2011"},{"issue":"4","key":"2025052505463247400_ref39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1056\/NEJMoa2202106","article-title":"Supplemental vitamin D and incident fractures in midlife and older adults","volume":"387","author":"LeBoff","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"2025052505463247400_ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-021-00893-x","article-title":"Multivitamins and risk of fragility hip fracture: a systematic review and meta-analysis","volume":"16","author":"Beeram","year":"2021","journal-title":"Arch Osteoporos"},{"key":"2025052505463247400_ref41","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqac056","article-title":"Multivitamins in the prevention of cancer and cardiovascular disease: the COSMOS randomized clinical trial","volume":"115","author":"Sesso","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"2025052505463247400_ref42","doi-asserted-by":"publisher","first-page":"107078","DOI":"10.1016\/j.cct.2023.107078","article-title":"Rationale and design of an ancillary study evaluating the effects of the cocoa flavanol and\/or multivitamin interventions on falls and physical performance outcomes in the COcoa Supplement and Multivitamin Outcomes Study (COSMOS)","volume":"125","author":"LeBoff","year":"2023","journal-title":"Contemp Clin Trials"},{"issue":"23","key":"2025052505463247400_ref43","doi-asserted-by":"publisher","first-page":"e2216932120","DOI":"10.1073\/pnas.2216932120","article-title":"Dietary flavanols restore hippocampal-dependent memory in older adults with lower diet quality and lower habitual flavanol consumption","volume":"120","author":"Brickman","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2025052505463247400_ref44","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3945\/jn.111.157222","article-title":"Alternative dietary indices both strongly predict risk of chronic disease","volume":"142","author":"Chiuve","year":"2012","journal-title":"J Nutr"},{"issue":"1","key":"2025052505463247400_ref45","doi-asserted-by":"publisher","first-page":"9859","DOI":"10.1038\/s41598-018-28333-w","article-title":"Evaluation at scale of microbiome-derived metabolites as biomarker of flavan-3-ol intake in epidemiological studies","volume":"8","author":"Ottaviani","year":"2018","journal-title":"Sci Rep"},{"issue":"18","key":"2025052505463247400_ref46","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1093\/jnci\/85.18.1492","article-title":"Nutrition intervention trials in Linxian, China: multiple vitamin\/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia","volume":"85","author":"Li","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2025052505463247400_ref47","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s00774-014-0589-3","article-title":"Multivitamin and mineral supplementation is associated with the reduction of fracture risk and hospitalization rate in Chinese adult males: a randomized controlled study","volume":"33","author":"Wang","year":"2014","journal-title":"J Bone Miner Metab"},{"issue":"23","key":"2025052505463247400_ref48","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1001\/jama.2021.15650","article-title":"Vitamin and mineral supplements for the primary prevention of cardiovascular disease and cancer: updated evidence report and systematic review for the US preventive services task force","volume":"327","author":"O'Connor","year":"2022","journal-title":"JAMA"},{"issue":"3","key":"2025052505463247400_ref49","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.ajcnut.2023.12.011","article-title":"Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS","volume":"119","author":"Vyas","year":"2024","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"2025052505463247400_ref50","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/01.GME.0000094210.15096.FD","article-title":"Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials","volume":"11","author":"Chen","year":"2004","journal-title":"Menopause"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjaf030\/61940792\/zjaf030.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjaf030\/61940792\/zjaf030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjaf030\/61940792\/zjaf030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T09:46:41Z","timestamp":1748166401000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/40\/5\/591\/8020503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,2,18]]},"published-print":{"date-parts":[[2025,5,24]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjaf030","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,2,18]]}}}